{"id":"https://openalex.org/W4223554014","doi":"https://doi.org/10.1186/s13045-022-01257-9","title":"Targeting Fc\u03b3RIIB by antagonistic antibody BI-1206 improves the efficacy of rituximab-based therapies in aggressive mantle cell lymphoma","display_name":"Targeting Fc\u03b3RIIB by antagonistic antibody BI-1206 improves the efficacy of rituximab-based therapies in aggressive mantle cell lymphoma","publication_year":2022,"publication_date":"2022-04-11","ids":{"openalex":"https://openalex.org/W4223554014","doi":"https://doi.org/10.1186/s13045-022-01257-9","pmid":"https://pubmed.ncbi.nlm.nih.gov/35410313","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/8996600"},"language":"en","primary_location":{"id":"doi:10.1186/s13045-022-01257-9","doi":"https://doi.org/10.1186/s13045-022-01257-9","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s13045-022-01257-9","pdf_url":"https://jhoonline.biomedcentral.com/track/pdf/10.1186/s13045-022-01257-9","source":{"id":"https://openalex.org/S46507181","display_name":"Journal of Hematology & Oncology","issn_l":"1756-8722","issn":["1756-8722"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-1","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Hematology &amp; Oncology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://jhoonline.biomedcentral.com/track/pdf/10.1186/s13045-022-01257-9","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5068376154","display_name":"Changying Jiang","orcid":"https://orcid.org/0000-0003-3778-4438","observed_orcids":["https://orcid.org/0000-0003-3778-4438"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Vivian Changying Jiang","raw_affiliation_strings":["Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX, USA","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100355813","display_name":"Yang Liu","orcid":"https://orcid.org/0000-0002-1910-8076","observed_orcids":["https://orcid.org/0000-0002-1910-8076"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yang Liu","raw_affiliation_strings":["Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX, USA","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022585377","display_name":"Alexa A Jordan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alexa Jordan","raw_affiliation_strings":["Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX, USA","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042253574","display_name":"Angela Leeming","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Angela Leeming","raw_affiliation_strings":["Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX, USA","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083447411","display_name":"Joseph Mitchell McIntosh","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joseph McIntosh","raw_affiliation_strings":["Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX, USA","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102378485","display_name":"Shengjian Huang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Shengjian Huang","raw_affiliation_strings":["Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX, USA","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003478727","display_name":"Rongjia Zhang","orcid":"https://orcid.org/0000-0003-1006-6866","observed_orcids":["https://orcid.org/0000-0003-1006-6866"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rongjia Zhang","raw_affiliation_strings":["Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX, USA","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102008416","display_name":"Qingsong Cai","orcid":"https://orcid.org/0000-0003-2439-4051","observed_orcids":["https://orcid.org/0000-0003-2439-4051"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Qingsong Cai","raw_affiliation_strings":["Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX, USA","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100430127","display_name":"Zhihong Chen","orcid":"https://orcid.org/0000-0002-7056-1335","observed_orcids":["https://orcid.org/0000-0002-7056-1335"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Zhihong Chen","raw_affiliation_strings":["Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX, USA","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5115603033","display_name":"Yijing Li","orcid":"https://orcid.org/0009-0000-0338-1935","observed_orcids":["https://orcid.org/0009-0000-0338-1935"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yijing Li","raw_affiliation_strings":["Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX, USA","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101503606","display_name":"Yuxuan Che","orcid":"https://orcid.org/0000-0002-0714-6411","observed_orcids":["https://orcid.org/0000-0002-0714-6411"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yuxuan Che","raw_affiliation_strings":["Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX, USA","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Lei Nie","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lei Nie","raw_affiliation_strings":["Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX, USA","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065612884","display_name":"Ingrid Karlsson","orcid":"https://orcid.org/0009-0006-2466-919X","observed_orcids":["https://orcid.org/0009-0006-2466-919X"]},"institutions":[{"id":"https://openalex.org/I4210141808","display_name":"BioInvent (Sweden)","ror":"https://ror.org/047866h90","country_code":"SE","type":"company","lineage":["https://openalex.org/I4210141808"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Ingrid Karlsson","raw_affiliation_strings":["BioInvent International AB, Lund, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"BioInvent International AB, Lund, Sweden","institution_ids":["https://openalex.org/I4210141808"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108728970","display_name":"Linda M\u00e5rtensson","orcid":"https://orcid.org/0009-0002-9518-7359","observed_orcids":["https://orcid.org/0009-0002-9518-7359"]},"institutions":[{"id":"https://openalex.org/I4210141808","display_name":"BioInvent (Sweden)","ror":"https://ror.org/047866h90","country_code":"SE","type":"company","lineage":["https://openalex.org/I4210141808"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Linda M\u00e5rtensson","raw_affiliation_strings":["BioInvent International AB, Lund, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"BioInvent International AB, Lund, Sweden","institution_ids":["https://openalex.org/I4210141808"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023906837","display_name":"Mathilda Kovacek","orcid":"https://orcid.org/0009-0002-5156-7261","observed_orcids":["https://orcid.org/0009-0002-5156-7261"]},"institutions":[{"id":"https://openalex.org/I4210141808","display_name":"BioInvent (Sweden)","ror":"https://ror.org/047866h90","country_code":"SE","type":"company","lineage":["https://openalex.org/I4210141808"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Mathilda Kovacek","raw_affiliation_strings":["BioInvent International AB, Lund, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"BioInvent International AB, Lund, Sweden","institution_ids":["https://openalex.org/I4210141808"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049258782","display_name":"Ingrid Teige","orcid":"https://orcid.org/0009-0007-5996-3396","observed_orcids":["https://orcid.org/0009-0007-5996-3396"]},"institutions":[{"id":"https://openalex.org/I4210141808","display_name":"BioInvent (Sweden)","ror":"https://ror.org/047866h90","country_code":"SE","type":"company","lineage":["https://openalex.org/I4210141808"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Ingrid Teige","raw_affiliation_strings":["BioInvent International AB, Lund, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"BioInvent International AB, Lund, Sweden","institution_ids":["https://openalex.org/I4210141808"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013771543","display_name":"Bj\u00f6rn Frend\u00e9us","orcid":"https://orcid.org/0000-0003-3177-8686","observed_orcids":["https://orcid.org/0000-0003-3177-8686"]},"institutions":[{"id":"https://openalex.org/I4210141808","display_name":"BioInvent (Sweden)","ror":"https://ror.org/047866h90","country_code":"SE","type":"company","lineage":["https://openalex.org/I4210141808"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Bj\u00f6rn Frend\u00e9us","raw_affiliation_strings":["BioInvent International AB, Lund, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"BioInvent International AB, Lund, Sweden","institution_ids":["https://openalex.org/I4210141808"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5100438316","display_name":"Michael L. Wang","orcid":"https://orcid.org/0000-0001-9748-5486","observed_orcids":["https://orcid.org/0000-0001-9748-5486"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Michael Wang","raw_affiliation_strings":["Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX, USA. miwang@mdanderson.org","Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. miwang@mdanderson.org","Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA"],"raw_orcid":"https://orcid.org/0000-0001-9748-5486","affiliations":[{"raw_affiliation_string":"Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX, USA. miwang@mdanderson.org","institution_ids":["https://openalex.org/I1343551460"]},{"raw_affiliation_string":"Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. miwang@mdanderson.org","institution_ids":["https://openalex.org/I1343551460"]},{"raw_affiliation_string":"Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA","institution_ids":["https://openalex.org/I1343551460"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5100438316"],"corresponding_institution_ids":["https://openalex.org/I1343551460"],"apc_list":{"value":4190,"currency":"USD","value_usd":4190},"apc_paid":{"value":4190,"currency":"USD","value_usd":4190},"fwci":1.8131,"has_fulltext":true,"cited_by_count":10,"citation_normalized_percentile":{"value":0.85440506,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"15","issue":"1","first_page":"42","last_page":"42"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.9746000170707703,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.9746000170707703,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.0215000007301569,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/fcgammariib","display_name":"Fc\u03b3RIIB","score":0.9869999885559082},{"id":"https://openalex.org/keywords/rituximab-resistance","display_name":"rituximab resistance","score":0.8949999809265137},{"id":"https://openalex.org/keywords/ibrutinib-resistance","display_name":"ibrutinib resistance","score":0.7749999761581421},{"id":"https://openalex.org/keywords/venetoclax-resistance","display_name":"venetoclax resistance","score":0.9919999837875366},{"id":"https://openalex.org/keywords/immune-checkpoint","display_name":"immune checkpoint","score":0.4300000071525574},{"id":"https://openalex.org/keywords/lenalidomide","display_name":"lenalidomide","score":0.7760000228881836}],"concepts":[{"id":"https://openalex.org/C2780653079","wikidata":"https://www.wikidata.org/wiki/Q412323","display_name":"Rituximab","level":3,"score":0.8657141923904419},{"id":"https://openalex.org/C2777525834","wikidata":"https://www.wikidata.org/wiki/Q268713","display_name":"Mantle cell lymphoma","level":3,"score":0.7615944147109985},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7191908359527588},{"id":"https://openalex.org/C2779675984","wikidata":"https://www.wikidata.org/wiki/Q23671272","display_name":"Venetoclax","level":4,"score":0.7080305814743042},{"id":"https://openalex.org/C2779878957","wikidata":"https://www.wikidata.org/wiki/Q5984881","display_name":"Ibrutinib","level":4,"score":0.6768525242805481},{"id":"https://openalex.org/C18031839","wikidata":"https://www.wikidata.org/wiki/Q5009796","display_name":"CD20","level":3,"score":0.5171677470207214},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.4717883765697479},{"id":"https://openalex.org/C2779725641","wikidata":"https://www.wikidata.org/wiki/Q1076228","display_name":"CHOP","level":3,"score":0.4665859341621399},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.4521007537841797},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.42986100912094116},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3378635346889496},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.33503061532974243},{"id":"https://openalex.org/C2777938653","wikidata":"https://www.wikidata.org/wiki/Q1088156","display_name":"Chronic lymphocytic leukemia","level":3,"score":0.2507162094116211},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.19909772276878357}],"mesh":[{"descriptor_ui":"D000069283","descriptor_name":"Rituximab","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000069283","descriptor_name":"Rituximab","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000076962","descriptor_name":"Receptors, Chimeric Antigen","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009364","descriptor_name":"Neoplasm Recurrence, Local","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D018951","descriptor_name":"Antigens, CD20","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020522","descriptor_name":"Lymphoma, Mantle-Cell","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D058846","descriptor_name":"Antibodies, Monoclonal, Murine-Derived","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1186/s13045-022-01257-9","doi":"https://doi.org/10.1186/s13045-022-01257-9","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s13045-022-01257-9","pdf_url":"https://jhoonline.biomedcentral.com/track/pdf/10.1186/s13045-022-01257-9","source":{"id":"https://openalex.org/S46507181","display_name":"Journal of Hematology & Oncology","issn_l":"1756-8722","issn":["1756-8722"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-1","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Hematology &amp; Oncology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:8996600","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/8996600","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"J Hematol Oncol","raw_type":"Text"},{"id":"pmid:35410313","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/35410313","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of hematology & oncology","raw_type":"Letter"},{"id":"pmh:oai:doaj.org/article:9f67a31b108c4b628eddafeb215126c0","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/9f67a31b108c4b628eddafeb215126c0","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Journal of Hematology & Oncology, Vol 15, Iss 1, Pp 1-7 (2022)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1186/s13045-022-01257-9","doi":"https://doi.org/10.1186/s13045-022-01257-9","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s13045-022-01257-9","pdf_url":"https://jhoonline.biomedcentral.com/track/pdf/10.1186/s13045-022-01257-9","source":{"id":"https://openalex.org/S46507181","display_name":"Journal of Hematology & Oncology","issn_l":"1756-8722","issn":["1756-8722"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-1","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Hematology &amp; Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9907000064849854,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G9000878657","display_name":"Cancer Center Support Grant","funder_award_id":"P30CA016672","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4223554014.pdf","grobid_xml":"https://content.openalex.org/works/W4223554014.grobid-xml"},"referenced_works_count":6,"referenced_works":["https://openalex.org/W2003244776","https://openalex.org/W2009109361","https://openalex.org/W2010329820","https://openalex.org/W2034496537","https://openalex.org/W2115450015","https://openalex.org/W3094922365"],"related_works":["https://openalex.org/W3094836633","https://openalex.org/W2982985811","https://openalex.org/W2010329820","https://openalex.org/W4226198876","https://openalex.org/W2559089327","https://openalex.org/W2516407760","https://openalex.org/W4248934506","https://openalex.org/W2953195541","https://openalex.org/W4379981819","https://openalex.org/W1976347766"],"abstract_inverted_index":{"Abstract":[0,311],"Inevitable":[1],"relapses":[2],"remain":[3],"as":[4,199],"the":[5,37,43,58,167,184,229,243,268,271,298],"major":[6],"therapeutic":[7,299],"challenge":[8],"in":[9,32,49,77,96,110,128,168,187,213,248,283,304],"patients":[10,78],"with":[11,79,84,137,148,252,308],"mantle":[12],"cell":[13,51,55,99,189],"lymphoma":[14],"(MCL)":[15],"despite":[16],"FDA":[17],"approval":[18],"of":[19,42,172,231,238,245,270,285,301],"multiple":[20],"targeted":[21],"therapies":[22,147],"and":[23,53,62,73,101,151,177,224,233,258],"immunotherapies.":[24],"Fc":[25],"gamma":[26],"receptors":[27],"(Fc\u03b3Rs)":[28],"play":[29],"important":[30],"roles":[31],"regulating":[33],"antibody-mediated":[34,64],"immunity.":[35],"Fc\u03b3RIIB,":[36],"unique":[38],"immune-checkpoint":[39,295],"inhibitory":[40],"member":[41],"Fc\u03b3R":[44],"family,":[45],"has":[46],"been":[47],"implicated":[48],"immune":[50],"desensitization":[52],"tumor":[54,281],"resistance":[56,254],"to":[57,119,210,221,228,255,279],"anti-CD20":[59],"antibody":[60,143],"rituximab":[61,232,246],"other":[63],"immunotherapies;":[65],"however,":[66],"little":[67],"is":[68,107,219],"known":[69],"about":[70],"its":[71,74],"expression":[72,106],"immune-modulatory":[75],"function":[76],"aggressive":[80,215,305],"MCL,":[81],"especially":[82],"those":[83],"multi-resistance.":[85,309],"In":[86,193],"this":[87,293],"study,":[88],"we":[89],"found":[90],"that":[91,218,291],"Fc\u03b3RIIB":[92,105],"was":[93,131,158],"ubiquitously":[94],"expressed":[95],"both":[97,222],"MCL":[98,306],"lines":[100],"primary":[102],"patient":[103,113],"samples.":[104,124],"significantly":[108,165,266],"higher":[109],"CAR":[111,259],"T-relapsed":[112],"samples":[114],"(p":[115,174,179,206,261,274],"<":[116,207,275],"0.0001)":[117],"compared":[118,209],"ibrutinib/rituximab-na\u00efve,":[120],"sensitive":[121,227],"or":[122],"resistant":[123,220],"Rituximab-induced":[125],"CD20":[126,155],"internalization":[127,156],"JeKo-1":[129,188],"cells":[130],"completely":[132],"blocked":[133,161],"by":[134,162],"concurrent":[135],"treatment":[136],"BI-1206,":[138,198],"a":[139,200,249],"recombinant":[140],"human":[141],"monoclonal":[142],"targeting":[144,292],"Fc\u03b3RIIB.":[145],"Combinational":[146],"rituximab-ibrutinib,":[149],"rituximab-venetoclax":[150,178,272],"rituximab-CHOP":[152,185],"also":[153],"induced":[154],"which":[157,277],"again":[159],"effectively":[160],"BI-1206.":[163],"BI-1206":[164,241,265],"enhanced":[166,267],"vivo":[169],"anti-MCL":[170],"efficacy":[171,244,269],"rituximab-ibrutinib":[173],"=":[175,180,262],"0.05)":[176],"0.02),":[181],"but":[182,226],"not":[183],"combination":[186,230,273],"line-derived":[190],"xenograft":[191,195],"models.":[192],"patient-derived":[194],"(PDX)":[196],"models,":[197],"single":[201],"agent,":[202],"showed":[203],"high":[204],"potency":[205],"0.0001,":[208],"vehicle":[211],"control)":[212],"one":[214],"PDX":[216,250],"model":[217,251],"ibrutinib":[223,257],"venetoclax":[225],"lenalidomide":[234],"(the":[235],"preclinical":[236],"mimetic":[237],"R2":[239],"therapy).":[240],"sensitized":[242],"monotherapy":[247],"triple":[253],"rituximab,":[256],"T-therapies":[260],"0.030).":[263],"Moreover,":[264],"0.05),":[276],"led":[278],"long-term":[280],"remission":[282],"25%":[284],"mice.":[286],"Altogether,":[287],"these":[288],"data":[289],"support":[290],"new":[294],"blockade":[296],"enhances":[297],"activity":[300],"rituximab-based":[302],"regimens":[303],"models":[307],"Graphical":[310]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2022-04-15T00:00:00"}